Any statements, including those that may relate to new product plans, future clinical trials, business prospects and competitive products, are forward-looking statements.

Actual results might differ materially from these statements due to risks and uncertainties, including the uncertainties relating to clinical trials, the requirement for regulatory approval of products by the FDA and other regulatory agencies, impact of competitive products and pricing, market acceptance of new products, conditions in the market, enforcement of Therabron Therapeutics intellectual property rights, and access to and enforcement of the intellectual property rights of others.

Therabron Therapeutics disclaims any intent or obligation to update these forward-looking statements.